ISSN: 1055-9965

Cancer Epidemiology Biomarkers and Prevention Q1 Unclaimed

American Association for Cancer Research Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Epidemiology Biomarkers and Prevention is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 192. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system The scope of the journal is focused on Oncology, Cancer, Epidemiology, Genetics, Molecular Eidemiology, Biomarkers. It has an SJR impact factor of 2,234 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,234.

Cancer Epidemiology Biomarkers and Prevention focuses its scope in these topics and keywords: cancer, breast, hpv, colorectal, risk, diagnosis, lung, late, type, highrisk, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Epidemiology (Q1) Medicine (miscellaneous) (Q1) Oncology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,234

SJR Impact factor

192

H Index

297

Total Docs (Last Year)

699

Total Docs (3 years)

14037

Total Refs

3175

Total Cites (3 years)

625

Citable Docs (3 years)

3,61

Cites/Doc (2 years)

47,26

Ref/Doc

Other journals with similar parameters

Nature Reviews Drug Discovery Q1
Annual Review of Pathology: Mechanisms of Disease Q1
NCHS data brief Q1
Molecular Systems Biology Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Reduced Plasma Level of CXC Chemokine Ligand 7 in Patients with Pancreatic Cancer

-3 and -6 Polyunsaturated Fatty Acid Intakes and the Risk of Breast Cancer in Mexican Women: Impact of Obesity Status

Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer

Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students

Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer

Feasibility Study for Collection of HER2 Data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Central Cancer Registries

Serum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic Masses

Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2

Shift Work, Chronotype, and Melatonin Patterns among Female Hospital Employees on Day and Night Shifts

Associations between Arsenic Exposure and Global Posttranslational Histone Modifications among Adults in Bangladesh

"Journals Should Publish All ""Null"" Results and Should Sparingly Publish ""Positive"" Results"

Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men

SHOW MORE ARTICLES

Anal Human Papillomavirus Infection in Women and Its Relationship with Cervical Infection

Fred F. Kadlubar: In Memoriam (1946-2010)

Impact of Neighborhood and Individual Socioeconomic Status on Survival after Breast Cancer Varies by Race/Ethnicity: The Neighborhood and Breast Cancer Study

Tea Consumption and Risk of Breast Cancer

Development and Validation of a New, Sensitive Immunochemical Assay for O6-Methylguanine in DNA and Its Application in a Population Study

Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population

Cutting Cost and Increasing Access to Colorectal Cancer Screening: Another Approach to Following the Guidelines

Chlamydial Antibodies and Risk of Prostate Cancer

Plasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective Study

Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent

Evaluation of an ELISA for p16INK4a as a Screening Test for Cervical Cancer

Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .